NPA, Retailers Tackle Accountability: Health & Wellness Industry News Roundup

NPA, retailers tackle farm-to-shelf accountability; Probiotic best practices from CRN, IPA; Born Wild to incubate food, beverage brands; and more news in brief.

The Natural Products Association and major dietary supplement, natural food and mass merchandise retailers tackle the growing challenge of state officials and other authorities alleging that vitamins and supplements are adulterated with the Supplement Safety and Compliance Initiative. NPA on Jan. 11 said the SSCI, with national health and wellness retailers [GNC Holdings Inc.] and [Vitamin Shoppe Inc.], discount retail giant Walmart and leading natural products chain Whole Foods Market, targets reducing "supplement safety risks, recalls and harms by delivering equivalence and convergence between effective supplement safety management system.

More from United States

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

 

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

FDA Clears Qnovia’s NRT Inhalation IND, Commits To ‘Stimulating’ Smoking Cessation Innovation

 

Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

Adcomm Reform: Getting Needed Information More Important Than Vote Or Discussion

 

US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.

More from North America